Mostrar el registro sencillo del ítem

dc.creatorTziastoudi M., Stefanidis I., Zintzaras E.en
dc.date.accessioned2023-01-31T10:21:47Z
dc.date.available2023-01-31T10:21:47Z
dc.date.issued2020
dc.identifier10.1093/CKJ/SFAA077
dc.identifier.issn20488505
dc.identifier.urihttp://hdl.handle.net/11615/80246
dc.description.abstractDespite the extensive efforts of scientists, the genetic background of diabetic nephropathy (DN) has not yet been clarified. To elucidate the genetic variants that predispose to the development of DN, we conducted a systematic review and meta-analysis of all available genetic association studies (GAS) of DN. We searched in the Human Genome Epidemiology Navigator (HuGE Navigator) and PubMed for available GAS of DN. The threshold for meta-analysis was three studies per genetic variant. The association between genotype distribution and DN was examined using the generalized linear odds ratio (ORG). For variants with available allele frequencies, the examined model was the allele contrast. The pooled OR was estimated using the DerSimonian and Laird random effects model. The publication bias was assessed with Egger's test. We performed pathway analysis of significant genes with DAVID 6.7. Genetic data of 606 variants located in 228 genes were retrieved from 360 GASs and were synthesized with meta-analytic methods. ACACB, angiotensin I-converting enzyme (ACE), ADIPOQ, AGT, AGTR1, AKR1B1, APOC1, APOE, ATP1B2, ATP2A3, CARS, CCR5, CGNL1, Carnosine dipeptidase 1 (CNDP1), CYGB-PRCD, EDN1, Engulfment and cell motility 1 (ELMO1), ENPP1, EPO, FLT4, FTO, GLO1, HMGA2, IGF2/INS/TH cluster, interleukin 1B (IL1B), IL8, IL10, KCNQ1, KNG, LOC101927627, Methylenetetrahydrofolate reductase, nitric oxide synthase 3 (NOS3), SET domain containing seven, histone lysine methyltransferase (SETD7), Sirtuin 1 (SIRT1), SLC2A1, SLC2A2, SLC12A3, SLC19A3, TCF7L2, TGFB1, TIMP1, TTC39C, UNC13B, VEGFA, WTAPP1, WWC1 as well as XYLT1 and three intergenic polymorphisms showed significant association with DN. Pathway analysis revealed the overrepresentation of six signalling pathways.The significant findings provide further evidence for genetic factors implication in DN offering new perspectives in discovery of new therapies. © The Author(s) 2020. Published by Oxford University Press on behalf of ERA-EDTA. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.en
dc.language.isoenen
dc.sourceClinical Kidney Journalen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85101071282&doi=10.1093%2fCKJ%2fSFAA077&partnerID=40&md5=4be420d2eed87aba3f0c969a2e7f988c
dc.subject5,10 methylenetetrahydrofolate reductase (FADH2)en
dc.subjectacetyl coenzyme A carboxylaseen
dc.subjectacetyl coenzyme A carboxylase betaen
dc.subjectadipocytokineen
dc.subjectadiponectinen
dc.subjectapolipoprotein Een
dc.subjectcarnosine dipeptidase 1en
dc.subjectchemokine receptor CCR5en
dc.subjectdipeptidyl carboxypeptidaseen
dc.subjectendothelial nitric oxide synthaseen
dc.subjectengulfment and cell motility 1 proteinen
dc.subjectglucose transporter 1en
dc.subjectglucose transporter 2en
dc.subjecthigh mobility group A2 proteinen
dc.subjecthistone lysine methyltransferaseen
dc.subjectinterleukin 10en
dc.subjectinterleukin 1betaen
dc.subjectinterleukin 8en
dc.subjectpotassium channel KCNQ1en
dc.subjectpyruvic aciden
dc.subjectSET domain containing 7 histone lysine methyltransferaseen
dc.subjectsirtuin 1en
dc.subjectsodium chloride cotransporteren
dc.subjectsomatomedin Ben
dc.subjecttissue inhibitor of metalloproteinase 1en
dc.subjecttranscription factor 7 like 2en
dc.subjecttransforming growth factor beta1en
dc.subjectunclassified drugen
dc.subjectvasculotropin Aen
dc.subjectvasculotropin receptor 3en
dc.subjectACACB geneen
dc.subjectAGT geneen
dc.subjectAGTR1 geneen
dc.subjectAKR1B1 geneen
dc.subjectAPOC1 geneen
dc.subjectATP1B2 geneen
dc.subjectATP2A3 geneen
dc.subjectCARS geneen
dc.subjectCGNL1 geneen
dc.subjectCYGB-PRCD geneen
dc.subjectdiabetic nephropathyen
dc.subjectEDN1 geneen
dc.subjectendotheliumen
dc.subjectENPP1 geneen
dc.subjectepigeneticsen
dc.subjectEPO geneen
dc.subjectFTO geneen
dc.subjectgeneen
dc.subjectgene frequencyen
dc.subjectgene mappingen
dc.subjectgenetic associationen
dc.subjectgenetic variabilityen
dc.subjectgenotypeen
dc.subjectGLO1 geneen
dc.subjectheredityen
dc.subjecthumanen
dc.subjectinsulin dependent diabetes mellitusen
dc.subjectKNG geneen
dc.subjectlipid metabolismen
dc.subjectLOC101927627 geneen
dc.subjectMedlineen
dc.subjectmeta analysisen
dc.subjectmetabolismen
dc.subjectnon insulin dependent diabetes mellitusen
dc.subjectpriority journalen
dc.subjectrenal cell carcinomaen
dc.subjectrenin angiotensin aldosterone systemen
dc.subjectReviewen
dc.subjectsignal transductionen
dc.subjectsingle nucleotide polymorphismen
dc.subjectSLC19A3 geneen
dc.subjectsystematic reviewen
dc.subjectTTC39C geneen
dc.subjectUNC13B geneen
dc.subjectWTAPP1 geneen
dc.subjectWWC1 geneen
dc.subjectXYLT1 geneen
dc.subjectOxford University Pressen
dc.titleThe genetic map of diabetic nephropathy: Evidence from a systematic review and meta-analysis of genetic association studiesen
dc.typeotheren


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem